Article
Implantable telescope enters pivotal trial for AMD patients
Saratoga, CA-A pivotal trial has begun with the implantable miniature telescope (IMT) (VisionCare Ophthalmic Technologies Inc., Saratoga, CA), a low vision IOL for patients with age-related macular degeneration (AMD), following a successful phase I trial. In that trial, most patients gained three or more lines of near or distance visual acuity and improved their ability to perform daily activities.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
